Skip to main content

21.03.2024 | ORIGINALIE

Häufige und seltene Nebenwirkungen von injizierbaren Fillern

verfasst von: Prof. Dr. med. Berthold Rzany, ScM

Erschienen in: hautnah

Einloggen, um Zugang zu erhalten

Zusammenfassung

Im Umgang mit den unerwünschten Wirkungen von injizierbaren Fillern zeigt sich das Können des Behandlers. Häufige unerwünschte Wirkungen, wie Schwellungen und Hämatome, lassen sich per definitionem nicht vollständig vermeiden. Wichtig ist es, die Patienten auf diese unerwünschten Wirkungen hinzuweisen, ohne sie zu verängstigen und, falls notwendig, ein Behandlungskonzept anbieten zu können. Seltene unerwünschte Reaktionen sind schwerer zu vermeiden, weil zu den Risikofaktoren dieser Reaktionen nur wenig Evidenz vorhanden ist. Auch die Therapie ist hier schwieriger, weil viele Interventionen nicht auf ihre Wirksamkeit überprüft wurden.
Literatur
1.
Zurück zum Zitat Alijotas-Reig J, García-GImenez V, Velthuis PJ, Niessen FB, Decates TS (2022) Inflammatory immune-mediated adverse reactions induced by COVID-19 vaccines in previously injected patients with soft tissue fillers: a case series of 20 patients. J Cosmet Dermatol 21(8):3181–3187CrossRefPubMed Alijotas-Reig J, García-GImenez V, Velthuis PJ, Niessen FB, Decates TS (2022) Inflammatory immune-mediated adverse reactions induced by COVID-19 vaccines in previously injected patients with soft tissue fillers: a case series of 20 patients. J Cosmet Dermatol 21(8):3181–3187CrossRefPubMed
2.
Zurück zum Zitat Beleznay K, Humphrey S, Carruthers JD, Carruthers A (2014) Vascular compromise from soft tissue augmentation: experience with 12 cases and recommendations for optimal outcomes. J Clin Aesthet Dermatol 7(9):37–43PubMedPubMedCentral Beleznay K, Humphrey S, Carruthers JD, Carruthers A (2014) Vascular compromise from soft tissue augmentation: experience with 12 cases and recommendations for optimal outcomes. J Clin Aesthet Dermatol 7(9):37–43PubMedPubMedCentral
3.
Zurück zum Zitat Colon J, Mirkin S, Hardigan P, Elias MJ, Jacobs RJ (2023) Adverse events reported from Hyaluronic acid dermal filler injections to the facial region: a systematic review and meta-analysis. Cureus 15(4):e38286PubMedPubMedCentral Colon J, Mirkin S, Hardigan P, Elias MJ, Jacobs RJ (2023) Adverse events reported from Hyaluronic acid dermal filler injections to the facial region: a systematic review and meta-analysis. Cureus 15(4):e38286PubMedPubMedCentral
4.
Zurück zum Zitat De Maio M, Rzany B (2014) Injectable fillers in aesthetic medicine, 2. Aufl. Springer, Heidelberg. ISBN 978-3-642-45124‑9.CrossRef De Maio M, Rzany B (2014) Injectable fillers in aesthetic medicine, 2. Aufl. Springer, Heidelberg. ISBN 978-3-642-45124‑9.CrossRef
5.
Zurück zum Zitat Decates TS, Sayghani F, van Loghem JA, Velthuis PJ (2022) The Dutch Hyacorp® filler catastrophe: new EU legislation will prevent this from happening again. Eur J Dermatol 32(5):584–588CrossRefPubMed Decates TS, Sayghani F, van Loghem JA, Velthuis PJ (2022) The Dutch Hyacorp® filler catastrophe: new EU legislation will prevent this from happening again. Eur J Dermatol 32(5):584–588CrossRefPubMed
6.
7.
Zurück zum Zitat Farr C, Menzel J, Seeberger J, Schweigle B (1997) Clinical pharmacology and possible applications of hyaluronidase with reference to Hylase “Dessau”. Wien Med Wochenschr 147(15):347–355PubMed Farr C, Menzel J, Seeberger J, Schweigle B (1997) Clinical pharmacology and possible applications of hyaluronidase with reference to Hylase “Dessau”. Wien Med Wochenschr 147(15):347–355PubMed
8.
Zurück zum Zitat Goodman GJ, Magnusson MR, Callan P, Roberts S, Hart S, McDonald CB, Clague M, Rudd A, Bekhor PS, Liew S, Molton M, Wallace K, Corduff N, Arendse S, Manoharan S, Shamban A, Heydenrych I, Bhatia AC, Peng P, Pavicic T, Kapoor KM, Kosenko DE (2020) A consensus on minimizing the risk of hyaluronic acid embolic visual loss and suggestions for immediate bedside management. Aesthet Surg J 40(9):1009–1021CrossRefPubMed Goodman GJ, Magnusson MR, Callan P, Roberts S, Hart S, McDonald CB, Clague M, Rudd A, Bekhor PS, Liew S, Molton M, Wallace K, Corduff N, Arendse S, Manoharan S, Shamban A, Heydenrych I, Bhatia AC, Peng P, Pavicic T, Kapoor KM, Kosenko DE (2020) A consensus on minimizing the risk of hyaluronic acid embolic visual loss and suggestions for immediate bedside management. Aesthet Surg J 40(9):1009–1021CrossRefPubMed
9.
Zurück zum Zitat Goodman GJ, Magnusson MR, Callan P, Roberts S, Hart S, Lin F, Rahman E, McDonald CB, Liew S, Porter C, Corduff N, Clague M (2022) Aspiration before tissue filler—an exercise in futility and unsafe practice. Aesthet Surg J 42(1):89–101CrossRefPubMed Goodman GJ, Magnusson MR, Callan P, Roberts S, Hart S, Lin F, Rahman E, McDonald CB, Liew S, Porter C, Corduff N, Clague M (2022) Aspiration before tissue filler—an exercise in futility and unsafe practice. Aesthet Surg J 42(1):89–101CrossRefPubMed
10.
Zurück zum Zitat Goodman GJ, McDonald CB, Lim A, Porter CE, Deva AK, Magnusson M, Patel A, Hart S, Callan P, Rudd A, Roberts S, Wallace K, Bekhor P, Clague M, Williams L, Corduff N, Wines N, Al-Niaimi F, Fabi SG, Studniberg HM, Smith S, Tsirbas A, Arendse S, Ciconte A, Poon T (2023) Making sense of late tissue nodules associated with hyaluronic acid injections. Aesthet Surg J 43(6):NP438–NP448CrossRefPubMedPubMedCentral Goodman GJ, McDonald CB, Lim A, Porter CE, Deva AK, Magnusson M, Patel A, Hart S, Callan P, Rudd A, Roberts S, Wallace K, Bekhor P, Clague M, Williams L, Corduff N, Wines N, Al-Niaimi F, Fabi SG, Studniberg HM, Smith S, Tsirbas A, Arendse S, Ciconte A, Poon T (2023) Making sense of late tissue nodules associated with hyaluronic acid injections. Aesthet Surg J 43(6):NP438–NP448CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Kato JM, Matayoshi S (2022) Visual loss after aesthetic facial filler injection: a literature review on an ophthalmologic issue. Arq Bras Oftalmol 85(3):309–319CrossRefPubMed Kato JM, Matayoshi S (2022) Visual loss after aesthetic facial filler injection: a literature review on an ophthalmologic issue. Arq Bras Oftalmol 85(3):309–319CrossRefPubMed
12.
Zurück zum Zitat Lavikainen LI, Guyatt GH, Kalliala IEJ, Cartwright R, Luomaranta AL, Vernooij RWM, Tähtinen RM, Tadayon Najafabadi B, Singh T; ROTBIGGS Investigators; Pourjamal N, Oksjoki SM, Khamani N, Karjalainen PK, Joronen KM, Izett-Kay ML, Haukka J, Halme ALE, Ge FZ, Galambosi PJ, Devereaux PJ, Cárdenas JL, Couban RJ, Aro KM, Aaltonen RL, Tikkinen KAO. Risk of thrombosis and bleeding in gynecologic noncancer surgery: systematic review and meta-analysis. Am J Obstet Gynecol. 2023 Dec 10:S0002–9378(23)02117‑8. Lavikainen LI, Guyatt GH, Kalliala IEJ, Cartwright R, Luomaranta AL, Vernooij RWM, Tähtinen RM, Tadayon Najafabadi B, Singh T; ROTBIGGS Investigators; Pourjamal N, Oksjoki SM, Khamani N, Karjalainen PK, Joronen KM, Izett-Kay ML, Haukka J, Halme ALE, Ge FZ, Galambosi PJ, Devereaux PJ, Cárdenas JL, Couban RJ, Aro KM, Aaltonen RL, Tikkinen KAO. Risk of thrombosis and bleeding in gynecologic noncancer surgery: systematic review and meta-analysis. Am J Obstet Gynecol. 2023 Dec 10:S0002–9378(23)02117‑8.
13.
Zurück zum Zitat Park KE, Mehta P, Kherani F, Lee WW, Woodward JA, Foster JA, Zhang-Nunes S (2023) Response of 21 hyaluronic acid fillers to recombinant human hyaluronidase. Plast Reconstr Surg Glob Open 11(12):e5457CrossRefPubMedPubMedCentral Park KE, Mehta P, Kherani F, Lee WW, Woodward JA, Foster JA, Zhang-Nunes S (2023) Response of 21 hyaluronic acid fillers to recombinant human hyaluronidase. Plast Reconstr Surg Glob Open 11(12):e5457CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Pérez-Pérez L, García-Gavín J, Wortsman X, Santos-Briz Á (2017) Delayed Adverse Subcutaneous Reaction to a New Family of Hyaluronic Acid Dermal Fillers With Clinical, Ultrasound, and Histologic Correlation.Dermatol Surg 43(4):605–608 Pérez-Pérez L, García-Gavín J, Wortsman X, Santos-Briz Á (2017) Delayed Adverse Subcutaneous Reaction to a New Family of Hyaluronic Acid Dermal Fillers With Clinical, Ultrasound, and Histologic Correlation.Dermatol Surg 43(4):605–608
15.
Zurück zum Zitat Pérez-Ruiz C, Barabash-Neila R, Zulueta-Dorado T, Conejo-Mir Sánchez J (2019) Adverse granulomatous reaction to silicone filler treated with methotrexate. Dermatol Surg 45(3):489–492CrossRefPubMed Pérez-Ruiz C, Barabash-Neila R, Zulueta-Dorado T, Conejo-Mir Sánchez J (2019) Adverse granulomatous reaction to silicone filler treated with methotrexate. Dermatol Surg 45(3):489–492CrossRefPubMed
16.
Zurück zum Zitat Philibert F, Gras-Champel V, Chaby G et al (2020) Eruptive granuloma after injection of Ellansé® successfully treated using methotrexate. Ann Dermatol Venereol 147(8–9):525–529CrossRefPubMed Philibert F, Gras-Champel V, Chaby G et al (2020) Eruptive granuloma after injection of Ellansé® successfully treated using methotrexate. Ann Dermatol Venereol 147(8–9):525–529CrossRefPubMed
17.
Zurück zum Zitat Rzany B, DeLorenzi C (2015) Understanding, avoiding, and managing severe filler complications. Plast Reconstr Surg 36(5 Suppl):196S–203SCrossRef Rzany B, DeLorenzi C (2015) Understanding, avoiding, and managing severe filler complications. Plast Reconstr Surg 36(5 Suppl):196S–203SCrossRef
18.
Zurück zum Zitat Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R (1999) Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet 353(9171):2190–2194CrossRefPubMed Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R (1999) Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet 353(9171):2190–2194CrossRefPubMed
19.
Zurück zum Zitat Rzany B, Bachmann F, Nast A (2013) Adverse reaction to fillers. Diagnosis and management. Hautarzt 64(3):163–170CrossRefPubMed Rzany B, Bachmann F, Nast A (2013) Adverse reaction to fillers. Diagnosis and management. Hautarzt 64(3):163–170CrossRefPubMed
20.
Zurück zum Zitat Rzany B, Converset-Viethel S, Hartmann M, Larrouy JC, Ribé N, Sito G, Noize-Pin C (2019) Efficacy and safety of 3 new resilient Hyaluronic acid fillers, crosslinked with decreased BDDE, for the treatment of dynamic wrinkles: results of an 18-month, randomized controlled trial versus already available Comparators. Dermatol Surg 45(10):1304–1314CrossRefPubMed Rzany B, Converset-Viethel S, Hartmann M, Larrouy JC, Ribé N, Sito G, Noize-Pin C (2019) Efficacy and safety of 3 new resilient Hyaluronic acid fillers, crosslinked with decreased BDDE, for the treatment of dynamic wrinkles: results of an 18-month, randomized controlled trial versus already available Comparators. Dermatol Surg 45(10):1304–1314CrossRefPubMed
21.
Zurück zum Zitat Sharad J (2022) Hyaluronic acid filler injection for localized scleroderma—case report and review of literature on filler injections for localized scleroderma. Clin Cosmet Investig Dermatol 15:1627–1637CrossRefPubMedPubMedCentral Sharad J (2022) Hyaluronic acid filler injection for localized scleroderma—case report and review of literature on filler injections for localized scleroderma. Clin Cosmet Investig Dermatol 15:1627–1637CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Signorini M, Liew S, Sundaram H, De Boulle KL, Goodman GJ, Monheit G, Wu Y, Trindade de Almeida AR, Swift A, Vieira Braz A, Global Aesthetics Consensus Group (2016) Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers-evidence- and opinion-based review and consensus recommendations. Plast Reconstr Surg 137(6):961e–971eCrossRefPubMed Signorini M, Liew S, Sundaram H, De Boulle KL, Goodman GJ, Monheit G, Wu Y, Trindade de Almeida AR, Swift A, Vieira Braz A, Global Aesthetics Consensus Group (2016) Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers-evidence- and opinion-based review and consensus recommendations. Plast Reconstr Surg 137(6):961e–971eCrossRefPubMed
24.
Zurück zum Zitat Vasconcelos-Berg R, Izidoro JF, Wenz F, Müller A, Navarini AA, Sigrist RMS (2023) Doppler ultrasound-guided filler injections: useful tips to integrate ultrasound in daily practice. Aesthet Surg J 43(7):773–783CrossRefPubMed Vasconcelos-Berg R, Izidoro JF, Wenz F, Müller A, Navarini AA, Sigrist RMS (2023) Doppler ultrasound-guided filler injections: useful tips to integrate ultrasound in daily practice. Aesthet Surg J 43(7):773–783CrossRefPubMed
25.
Zurück zum Zitat Verner I, Naveh HP, Bertossi D (2019) Treatment of injection-induced ecchymoses with light/laser-assisted technology. Dermatol Ther 32(3):e12861CrossRefPubMed Verner I, Naveh HP, Bertossi D (2019) Treatment of injection-induced ecchymoses with light/laser-assisted technology. Dermatol Ther 32(3):e12861CrossRefPubMed
26.
Zurück zum Zitat Wilde CL, Gupta A, Lee S, Ezra DG (2023) Tear trough filler using the three-point tangent technique: lessons from 1452 tear trough applications. Plast Reconstr Surg Glob Open 11(6):e5060CrossRefPubMedPubMedCentral Wilde CL, Gupta A, Lee S, Ezra DG (2023) Tear trough filler using the three-point tangent technique: lessons from 1452 tear trough applications. Plast Reconstr Surg Glob Open 11(6):e5060CrossRefPubMedPubMedCentral
Metadaten
Titel
Häufige und seltene Nebenwirkungen von injizierbaren Fillern
verfasst von
Prof. Dr. med. Berthold Rzany, ScM
Publikationsdatum
21.03.2024
Verlag
Springer Vienna
Erschienen in
hautnah
Print ISSN: 1866-2250
Elektronische ISSN: 2192-6484
DOI
https://doi.org/10.1007/s12326-024-00629-x